EYPT

EyePoint Pharmaceuticals, Inc.NASDAQHealthcare

$13.40+2.92%ClosedMarket Cap: $1.12B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-09	Citigroup	—	Buy	—
2026-03-05	HC Wainwright & Co.	—	Buy	—
2026-03-04	Chardan Capital	—	Buy	—
2025-11-06	RBC Capital	—	Outperform	—
2025-08-07	Chardan Capital	—	Buy	—
2025-08-06	HC Wainwright & Co.	—	Buy	—
2025-05-29	HC Wainwright & Co.	—	Buy	—
2025-05-16	Mizuho	—	Outperform	—
2025-05-08	Chardan Capital	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-3.49	$51.8M	7
Sun Dec 31	$-0.99	$286.9M	7
Mon Dec 31	$1.09	$571.3M	2
Tue Dec 31	$2.91	$861.2M	5